Annual Cash & Cash Equivalents
$44.04 M
-$34.15 M-43.68%
31 December 2022
Summary:
Provention Bio annual cash & cash equivalents is currently $44.04 million, with the most recent change of -$34.15 million (-43.68%) on 31 December 2022. During the last 3 years, it has fallen by -$58.26 million (-56.95%).PRVB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$44.04 M
-$58.34 M-56.99%
31 December 2022
Summary:
Provention Bio quarterly cash and cash equivalents is currently $44.04 million, with the most recent change of -$58.34 million (-56.99%) on 31 December 2022.PRVB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRVB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -57.0% | -68.4% |
| 5 y5 years | -24.8% | -53.7% |
PRVB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -56.9% | -75.6% |
Provention Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $44.04 M(-43.7%) | $44.04 M(-57.0%) |
| Sept 2022 | - | $102.38 M(+76.9%) |
| June 2022 | - | $57.88 M(-22.7%) |
| Mar 2022 | - | $74.91 M(-4.2%) |
| Dec 2021 | $78.19 M(-23.6%) | $78.19 M(-43.9%) |
| Sept 2021 | - | $139.34 M(-8.2%) |
| June 2021 | - | $151.78 M(-15.8%) |
| Mar 2021 | - | $180.36 M(+76.3%) |
| Dec 2020 | $102.29 M | $102.29 M(-13.6%) |
| Sept 2020 | - | $118.44 M(-18.8%) |
| June 2020 | - | $145.89 M(+292.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $37.14 M(-5.2%) |
| Dec 2019 | $39.16 M(-33.1%) | $39.16 M(-58.8%) |
| Sept 2019 | - | $95.09 M(+130.5%) |
| June 2019 | - | $41.26 M(-19.4%) |
| Mar 2019 | - | $51.21 M(-12.5%) |
| Dec 2018 | $58.54 M(+168.1%) | $58.54 M(-9.0%) |
| Sept 2018 | - | $64.30 M(+529.8%) |
| June 2018 | - | $10.21 M(-35.6%) |
| Mar 2018 | - | $15.85 M(-27.4%) |
| Dec 2017 | $21.83 M(>+9900.0%) | $21.83 M |
| Dec 2016 | $0.00 | - |
FAQ
- What is Provention Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Provention Bio?
- What is Provention Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Provention Bio?
What is Provention Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of PRVB is $44.04 M
What is the all time high annual cash & cash equivalents for Provention Bio?
Provention Bio all-time high annual cash & cash equivalents is $102.29 M
What is Provention Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRVB is $44.04 M
What is the all time high quarterly cash and cash equivalents for Provention Bio?
Provention Bio all-time high quarterly cash and cash equivalents is $180.36 M